The bio-tech company Bunge Global SA (BG) has been involved in numerous significant events recently, causing the stock to be a focus of investor attention. One of the major developments is Bunge's successful acquisition of Viterra, worth $8.2 billion, after securing approval from China's regulators. This acquisition is perceived positively by market watchers and has triggered a rise in the company's shares. Bunge is also under a strong institutional backing with an 84% ownership.
Bunge has also reported its Q1 results in 2025 with an unexpected profit decrease but still managed to beat Wall Street estimates. The company has been maintaining its EPS guidance at $7.75 while focusing on strategic divestitures and acquisitions.
On top of this, Bunge's ongoing spree of strategic divestments includes selling its North America Corn Milling Business and terminating an agreement to acquire Brazilian soy processor CJ Selecta. There's also a reported divestment from seven corn milling facilities as part of strategic adjustment. Finally, Bunge has announced changes to its board of directors and approval of quarterly dividends at the 2025 Annual General Meeting.
Bunge Global Sa BG News Analytics from Fri, 07 Aug 2020 22:27:46 GMT to Sat, 14 Jun 2025 08:51:22 GMT - Rating 3 - Innovation 0 - Information 7 - Rumor -1
